{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:43:50Z","timestamp":1790516630384,"version":"4.1.0"},"reference-count":219,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prog Biomater"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s40204-018-0097-y","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T06:15:40Z","timestamp":1536560140000},"page":"175-205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":204,"title":["Cardiovascular stents: overview, evolution, and next generation"],"prefix":"10.1007","volume":"7","author":[{"given":"Setareh","family":"Borhani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Hassanajili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Hossein","family":"Ahmadi Tafti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahram","family":"Rabbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"key":"97_CR1","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jacc.2004.01.023","volume":"43","author":"A Abizaid","year":"2004","unstructured":"Abizaid A et al (2004) First human experience with the 17-beta-estradiol-eluting stent. J Am Coll Cardiol 43:1118\u20131121","journal-title":"J Am Coll Cardiol"},{"key":"97_CR2","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/ccd.21210","volume":"70","author":"A Abizaid","year":"2007","unstructured":"Abizaid A et al (2007) Randomized, double-blind, multicenter study of the polymer-based 17-\u03b2 estradiol-eluting stent for treatment of native coronary artery lesions: six-month results of the ETHOS I trial. Catheter Cardiovasc Interv 70:654\u2013660","journal-title":"Catheter Cardiovasc Interv"},{"key":"97_CR3","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.4244\/EIJV10I12A243","volume":"10","author":"A Abizaid","year":"2015","unstructured":"Abizaid A et al (2015) The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled. EuroIntervention 10:1396\u20131401","journal-title":"EuroIntervention"},{"key":"97_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.addr.2006.01.016","volume":"58","author":"G Acharya","year":"2006","unstructured":"Acharya G, Park K (2006) Mechanisms of controlled drug release from drug-eluting stents. Adv Drug Deliv Rev 58:387\u2013401","journal-title":"Adv Drug Deliv Rev"},{"key":"97_CR5","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/(SICI)1097-4628(19991017)74:3<655::AID-APP19>3.0.CO;2-N","volume":"74","author":"D Adil","year":"1999","unstructured":"Adil D (1999) Heparin-immobolized poly (2-hydroxyethylmethacrylate)-based microspheres. J Appl Sci 74:655\u2013662","journal-title":"J Appl Sci"},{"key":"97_CR6","unstructured":"Ahmed M (2011) Design and development of a prosthetic implant for cardiovascular reconstructions. Doctoral dissertation, University College London"},{"key":"97_CR7","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.amjcard.2005.04.040","volume":"96","author":"F Airoldi","year":"2005","unstructured":"Airoldi F et al (2005) 17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease. Am J Cardiol 96:664\u2013667","journal-title":"Am J Cardiol"},{"key":"97_CR8","unstructured":"Ajili SH (2008) Preparation, study and modeling of polyurethane\/polycaprolactone blend with shape memory effect in the range of body temperature. Doctoral dissertation, Tarbiat Modares University"},{"key":"97_CR9","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.actbio.2008.12.014","volume":"5","author":"SH Ajili","year":"2009","unstructured":"Ajili SH, Ebrahimi NG, Soleimani M (2009) Polyurethane\/polycaprolactane blend with shape memory effect as a proposed material for cardiovascular implants. Acta Biomater 5:1519\u20131530","journal-title":"Acta Biomater"},{"key":"97_CR10","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1001\/jama.284.14.1828","volume":"284","author":"J Al Suwaidi","year":"2000","unstructured":"Al Suwaidi J, Berger PB, Holmes DR Jr (2000) Coronary artery stents. JAMA 284:1828\u20131836","journal-title":"JAMA"},{"key":"97_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1021\/acsbiomaterials.7b00676","volume":"4","author":"GC Alexander","year":"2017","unstructured":"Alexander GC, Hwang PT, Chen J, J-a Kim, Brott BC, Yoon Y-S, Jun H-W (2017) Nanomatrix coated stent enhances endothelialization but reduces platelet, smooth muscle cell, and monocyte adhesion under physiologic conditions. ACS Biomater Sci Eng 4:107\u2013115","journal-title":"ACS Biomater Sci Eng"},{"key":"97_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11239-012-0696-8","volume":"34","author":"CL Alviar","year":"2012","unstructured":"Alviar CL et al (2012) Low-dose sirolimus-eluting hydroxyapatite coating on stents does not increase platelet activation and adhesion ex vivo. J Thromb Thrombolysis 34:91\u201398","journal-title":"J Thromb Thrombolysis"},{"key":"97_CR13","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.1021\/ma000291w","volume":"33","author":"TJ Anastasiou","year":"2000","unstructured":"Anastasiou TJ, Uhrich KE (2000) Novel polyanhydrides with enhanced thermal and solubility properties. Macromolecules 33:6217\u20136221","journal-title":"Macromolecules"},{"key":"97_CR14","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1002\/app.1994.070531203","volume":"53","author":"AK Andrianov","year":"1994","unstructured":"Andrianov AK, Payne LG, Visscher KB, Allcock HR, Langer R (1994) Hydrolytic degradation of ionically cross-linked polyphosphazene microspheres. J Appl Polym Sci 53:1573\u20131578","journal-title":"J Appl Polym Sci"},{"key":"97_CR15","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1161\/01.CIR.0000038982.49640.70","volume":"106","author":"MN Babapulle","year":"2002","unstructured":"Babapulle MN, Eisenberg MJ (2002a) Coated stents for the prevention of restenosis: part I. Circulation 106:2734\u20132740","journal-title":"Circulation"},{"key":"97_CR16","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1161\/01.CIR.0000038984.30279.89","volume":"106","author":"MN Babapulle","year":"2002","unstructured":"Babapulle MN, Eisenberg MJ (2002b) Coated stents for the prevention of restenosis: part II. Circulation 106:2859\u20132866","journal-title":"Circulation"},{"key":"97_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jconrel.2007.06.025","volume":"123","author":"B Balakrishnan","year":"2007","unstructured":"Balakrishnan B, Dooley JF, Kopia G, Edelman ER (2007) Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution. J Control Release 123:100\u2013108","journal-title":"J Control Release"},{"key":"97_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4244\/EIJV5I1A24","volume":"5","author":"M Basalus","year":"2009","unstructured":"Basalus M, Ankone M, Van Houwelingen G, De Man F, von Birgelen C (2009) Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy. EuroIntervention 5:157\u2013165","journal-title":"EuroIntervention"},{"key":"97_CR19","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/ccd.23273","volume":"79","author":"MW Basalus","year":"2012","unstructured":"Basalus MW et al (2012) Scanning electron microscopic assessment of coating irregularities and their precursors in unexpanded durable polymer-based drug-eluting stents. Catheter Cardiovasc Interv 79:644\u2013653","journal-title":"Catheter Cardiovasc Interv"},{"key":"97_CR20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s10439-015-1455-8","volume":"44","author":"JS Bergstr\u00f6m","year":"2016","unstructured":"Bergstr\u00f6m JS, Hayman D (2016) An overview of mechanical properties and material modeling of polylactide (PLA) for medical applications. Ann Biomed Eng 44:330\u2013340","journal-title":"Ann Biomed Eng"},{"key":"97_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijcard.2012.05.093","volume":"167","author":"CV Bourantas","year":"2013","unstructured":"Bourantas CV, Onuma Y, Farooq V, Zhang Y, Garcia-Garcia HM, Serruys PW (2013) Bioresorbable scaffolds: current knowledge, potentialities and limitations experienced during their first clinical applications. Int J Cardiol 167:11\u201321","journal-title":"Int J Cardiol"},{"key":"97_CR22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10237-013-0546-4","volume":"13","author":"F Bozsak","year":"2014","unstructured":"Bozsak F, Chomaz J-M, Barakat AI (2014) Modeling the transport of drugs eluted from stents: physical phenomena driving drug distribution in the arterial wall. Biomech Model Mechanobiol 13:327\u2013347","journal-title":"Biomech Model Mechanobiol"},{"key":"97_CR23","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1253\/circj.CJ-11-1416","volume":"76","author":"S Brugaletta","year":"2012","unstructured":"Brugaletta S et al (2012) Vascular compliance changes of the coronary vessel wall after bioresorbable vascular scaffold implantation in the treated and adjacent segments. Circ J 76:1616\u20131623","journal-title":"Circ J"},{"key":"97_CR24","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.actbio.2013.10.015","volume":"10","author":"R Busch","year":"2014","unstructured":"Busch R et al (2014) New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets. Acta Biomater 10:688\u2013700","journal-title":"Acta Biomater"},{"key":"97_CR25","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.4244\/EIJY14M07_11","volume":"10","author":"D Capodanno","year":"2015","unstructured":"Capodanno D et al (2015) Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry. EuroIntervention 10:1144\u20131153","journal-title":"EuroIntervention"},{"key":"97_CR216","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0735-1097(97)00189-7","volume":"30","author":"DS Celermajer","year":"1997","unstructured":"Celermajer DS (1997) Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol 30:325\u2013333","journal-title":"J Am Coll Cardiol"},{"key":"97_CR26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/bab.53","volume":"58","author":"K Chaloupka","year":"2011","unstructured":"Chaloupka K, Motwani M, Seifalian AM (2011) Development of a new lacrimal drainage conduit using POSS nanocomposite. Biotechnol Appl Biochem 58:363\u2013370","journal-title":"Biotechnol Appl Biochem"},{"key":"97_CR27","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1021\/bm7004615","volume":"8","author":"M-C Chen","year":"2007","unstructured":"Chen M-C et al (2007) Rapidly self-expandable polymeric stents with a shape-memory property. Biomacromol 8:2774\u20132780","journal-title":"Biomacromol"},{"key":"97_CR28","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1021\/acs.bioconjchem.5b00192","volume":"26","author":"W Chen","year":"2015","unstructured":"Chen W, Habraken TC, Hennink WE, Kok RJ (2015) Polymer-free drug-eluting stents: an overview of coating strategies and comparison with polymer-coated drug-eluting stents. Bioconjug Chem 26:1277\u20131288","journal-title":"Bioconjug Chem"},{"key":"97_CR29","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s11095-006-9174-3","volume":"24","author":"AH Chow","year":"2007","unstructured":"Chow AH, Tong HH, Chattopadhyay P, Shekunov BY (2007) Particle engineering for pulmonary drug delivery. Pharm Res 24:411\u2013437","journal-title":"Pharm Res"},{"key":"97_CR30","first-page":"422","volume":"2","author":"JR Costa","year":"2009","unstructured":"Costa JR et al (2009) 1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trial. JACC 2:422\u2013427","journal-title":"JACC"},{"key":"97_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/B978-0-12-396983-5.00020-X","volume-title":"Natural and synthetic biomedical polymers","author":"TT Dang","year":"2014","unstructured":"Dang TT, Nikkhah M, Memic A, Khademhosseini A (2014) Chapter 19\u2014Polymeric Biomaterials for Implantable Prostheses A2\u2014Kumbar, Sangamesh G. In: Laurencin CT, Deng M (eds) Natural and synthetic biomedical polymers. Elsevier, Oxford, pp 309\u2013331. https:\/\/doi.org\/10.1016\/B978-0-12-396983-5.00020-X"},{"key":"97_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1179\/030801800679206","volume":"25","author":"S Davis","year":"2000","unstructured":"Davis S (2000) Drug delivery systems. Interdiscip Sci Rev 25:175\u2013183","journal-title":"Interdiscip Sci Rev"},{"key":"97_CR33","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1533\/9780857093677.2.223","volume-title":"Coatings for biomedical applications","author":"M Driver","year":"2012","unstructured":"Driver M (2012) 7\u2014Coatings for cardiovascular devices: coronary stents. In: Coatings for biomedical applications. Woodhead Publishing, Sawston, pp 223\u2013250"},{"key":"97_CR34","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/jbm.820280811","volume":"28","author":"SI Ertel","year":"1994","unstructured":"Ertel SI, Kohn J (1994) Evaluation of a series of tyrosine-derived polycarbonates as degradable biomaterials. J Biomed Mater Res Part A 28:919\u2013930","journal-title":"J Biomed Mater Res Part A"},{"key":"97_CR35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1063\/1.1749836","volume":"4","author":"H Eyring","year":"1936","unstructured":"Eyring H (1936) Viscosity, plasticity, and diffusion as examples of absolute reaction rates. J Chem Phys 4:283\u2013291","journal-title":"J Chem Phys"},{"key":"97_CR36","doi-asserted-by":"publisher","first-page":"9010","DOI":"10.1021\/acsami.7b18733","volume":"10","author":"S Farah","year":"2018","unstructured":"Farah S (2018) Protective layer development for enhancing stability and drug-delivery capabilities of des surface-crystallized coatings. ACS Appl Mater Interfaces 10:9010\u20139022","journal-title":"ACS Appl Mater Interfaces"},{"key":"97_CR37","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1161\/01.CIR.0000091115.05480.B0","volume":"108","author":"A Farb","year":"2003","unstructured":"Farb A, Burke AP, Kolodgie FD, Virmani R (2003) Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108:1701\u20131706","journal-title":"Circulation"},{"key":"97_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1046\/j.1365-2613.2000.00143.x","volume":"81","author":"GA Ferns","year":"2000","unstructured":"Ferns GA, Avades TY (2000) The mechanisms of coronary restenosis: insights from experimental models. Int J Exp Pathol 81:63\u201388","journal-title":"Int J Exp Pathol"},{"key":"97_CR39","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1163\/156856294X00176","volume":"5","author":"J Fiordeliso","year":"1994","unstructured":"Fiordeliso J, Bron S, Kohn J (1994) Design, synthesis, and pr eliminary characterization of tyrosine-containing polyarylates: new biomaterials for medical applications. J Biomater Sci Polymer Edition 5:496\u2013510","journal-title":"J Biomater Sci Polymer Edition"},{"key":"97_CR40","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJM199408253310802","volume":"331","author":"DL Fischman","year":"1994","unstructured":"Fischman DL et al (1994) A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331:496\u2013501","journal-title":"N Engl J Med"},{"key":"97_CR41","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.1016\/j.biomaterials.2011.05.078","volume":"32","author":"S Franz","year":"2011","unstructured":"Franz S, Rammelt S, Scharnweber D, Simon JC (2011) Immune responses to implants\u2014a review of the implications for the design of immunomodulatory biomaterials. Biomaterials 32:6692\u20136709","journal-title":"Biomaterials"},{"key":"97_CR42","first-page":"1263","volume":"6","author":"H Gada","year":"2013","unstructured":"Gada H et al (2013) 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions). JACC 6:1263\u20131266","journal-title":"JACC"},{"key":"97_CR43","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.apsusc.2013.04.072","volume":"279","author":"A Gallo","year":"2013","unstructured":"Gallo A, Mani G (2013) A stent for co-delivering paclitaxel and nitric oxide from abluminal and luminal surfaces: preparation, surface characterization, and in vitro drug release studies. Appl Surf Sci 279:216\u2013232","journal-title":"Appl Surf Sci"},{"key":"97_CR44","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1136\/bmj.318.7184.650","volume":"318","author":"MM Gandhi","year":"1999","unstructured":"Gandhi MM, Dawkins KD (1999) Fortnightly review: intracoronary stents. BMJ 318:650","journal-title":"BMJ"},{"key":"97_CR45","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.jacc.2010.06.008","volume":"56","author":"S Garg","year":"2010","unstructured":"Garg S, Serruys PW (2010) Coronary stents: looking forward. J Am Coll Cardiol 56:S43\u2013S78","journal-title":"J Am Coll Cardiol"},{"key":"97_CR46","first-page":"91","volume":"1","author":"M Generali","year":"2014","unstructured":"Generali M, Dijkman PE, Hoerstrup SP (2014) Bioresorbable scaffolds for cardiovascular tissue engineering. Eur Med J Interv Cardiol 1:91\u201399","journal-title":"Eur Med J Interv Cardiol"},{"key":"97_CR47","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.amjcard.2003.08.017","volume":"92","author":"FJ Gijsen","year":"2003","unstructured":"Gijsen FJ et al (2003) Usefulness of shear stress pattern in predicting neointima distribution in sirolimus-eluting stents in coronary arteries. Am J Cardiol 92:1325\u20131328","journal-title":"Am J Cardiol"},{"key":"97_CR48","first-page":"1190","volume":"3","author":"J Gomez-Lara","year":"2010","unstructured":"Gomez-Lara J et al (2010) A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents. JACC 3:1190\u20131198","journal-title":"JACC"},{"key":"97_CR49","first-page":"789","volume":"4","author":"J Gomez-Lara","year":"2011","unstructured":"Gomez-Lara J et al (2011) Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up. JACC 4:789\u2013799","journal-title":"JACC"},{"key":"97_CR50","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/jctb.2282","volume":"85","author":"N Grabow","year":"2010","unstructured":"Grabow N, Martin DP, Schmitz KP, Sternberg K (2010) Absorbable polymer stent technologies for vascular regeneration. J Chem Technol Biotechnol 85:744\u2013751","journal-title":"J Chem Technol Biotechnol"},{"key":"97_CR51","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/macp.1994.021950516","volume":"195","author":"DW Grijpma","year":"1994","unstructured":"Grijpma DW, Pennings AJ (1994) (Co) polymers of l-lactide, 2. Mechanical properties. Macromol Chem Phys 195:1649\u20131663","journal-title":"Macromol Chem Phys"},{"key":"97_CR52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-3-642-46381-5_9","volume-title":"Percutaneous vascular recanalization","author":"A Gr\u00fcntzig","year":"1978","unstructured":"Gr\u00fcntzig A (1978) Transluminal dilatation of coronary artery stenosis\u2014experimental report. In: Percutaneous vascular recanalization. Springer, Berlin, Heidelberg, pp 57\u201365"},{"key":"97_CR53","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1533\/9780857090553.2.173","volume-title":"Biomaterials and devices for the circulatory system","author":"A Guildford","year":"2010","unstructured":"Guildford A, Santin M, Phillips GJ (2010) 7\u2014Cardiovascular stents A2\u2014Gourlay, terence. In: Black RA (ed) Biomaterials and devices for the circulatory system. Woodhead Publishing, Sawston, pp 173\u2013216. https:\/\/doi.org\/10.1533\/9780857090553.2.173"},{"key":"97_CR54","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/S0735-1097(00)00570-2","volume":"35","author":"M Gy\u00f6ngy\u00f6si","year":"2000","unstructured":"Gy\u00f6ngy\u00f6si M, Yang P, Khorsand A, Glogar D, Group AWSS, Investigators EPS (2000) Longitudinal straightening effect of stents is an additional predictor for major adverse cardiac events. J Am Coll Cardiol 35:1580\u20131589","journal-title":"J Am Coll Cardiol"},{"key":"97_CR55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10047-008-0456-x","volume":"12","author":"T Hanawa","year":"2009","unstructured":"Hanawa T (2009) Materials for metallic stents. J Artif Organs 12:73\u201379","journal-title":"J Artif Organs"},{"key":"97_CR56","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.addr.2006.01.022","volume":"58","author":"H Hara","year":"2006","unstructured":"Hara H, Nakamura M, Palmaz JC, Schwartz RS (2006) Role of stent design and coatings on restenosis and thrombosis. Adv Drug Deliv Rev 58:377\u2013386","journal-title":"Adv Drug Deliv Rev"},{"key":"97_CR57","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1161\/01.CIR.93.3.423","volume":"93","author":"PA H\u00e5rdhammar","year":"1996","unstructured":"H\u00e5rdhammar PA et al (1996) Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation 93:423\u2013430","journal-title":"Circulation"},{"key":"97_CR58","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.4244\/EIJ-D-15-00371","volume":"12","author":"M Haude","year":"2016","unstructured":"Haude M et al (2016a) Safety and performance of the DRug-Eluting Absorbable Metal Scaffold (DREAMS) in patients with de novo coronary lesions: 3-year results of the prospective, multicentre, first-in-man BIOSOLVE-I trial. EuroIntervention 12:e160\u2013e166","journal-title":"EuroIntervention"},{"key":"97_CR59","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)00447-X","volume":"387","author":"M Haude","year":"2016","unstructured":"Haude M et al (2016b) Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6\u00a0month results of a prospective, multicentre, non-randomised, first-in-man trial. Lancet 387:31\u201339","journal-title":"Lancet"},{"key":"97_CR60","doi-asserted-by":"publisher","first-page":"081006","DOI":"10.1115\/1.4027614","volume":"136","author":"D Hayman","year":"2014","unstructured":"Hayman D, Bergerson C, Miller S, Moreno M, Moore JE (2014) The effect of static and dynamic loading on degradation of PLLA stent fibers. J Biomech Eng 136:081006","journal-title":"J Biomech Eng"},{"key":"97_CR61","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.ijbiomac.2016.02.032","volume":"86","author":"M Hemshekhar","year":"2016","unstructured":"Hemshekhar M, Thushara RM, Chandranayaka S, Sherman LS, Kemparaju K, Girish KS (2016) Emerging roles of hyaluronic acid bioscaffolds in tissue engineering and regenerative medicine. Int J Biol Macromol 86:917\u2013928","journal-title":"Int J Biol Macromol"},{"key":"97_CR62","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/heart.89.6.651","volume":"89","author":"B Heublein","year":"2003","unstructured":"Heublein B, Rohde R, Kaese V, Niemeyer M, Hartung W, Haverich A (2003) Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology? Heart 89:651\u2013656","journal-title":"Heart"},{"key":"97_CR63","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1016\/j.actbio.2012.04.012","volume":"8","author":"H Hornberger","year":"2012","unstructured":"Hornberger H, Virtanen S, Boccaccini A (2012) Biomedical coatings on magnesium alloys\u2014a review. Acta Biomater 8:2442\u20132455","journal-title":"Acta Biomater"},{"key":"97_CR64","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.medengphy.2012.08.021","volume":"35","author":"H-M Hsiao","year":"2013","unstructured":"Hsiao H-M, Chiu Y-H, Wu T-Y, Shen J-K, Lee T-Y (2013) Effects of through-hole drug reservoirs on key clinical attributes for drug-eluting depot stent. Med Eng Phys 35:884\u2013897","journal-title":"Med Eng Phys"},{"key":"97_CR65","doi-asserted-by":"publisher","first-page":"11695","DOI":"10.1021\/acsami.5b01993","volume":"7","author":"T Hu","year":"2015","unstructured":"Hu T et al (2015) Controlled slow-release drug-eluting stents for the prevention of coronary restenosis: recent progress and future prospects. ACS Appl Mater Interfaces 7:11695\u201311712","journal-title":"ACS Appl Mater Interfaces"},{"key":"97_CR66","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.1016\/j.biomaterials.2010.01.147","volume":"31","author":"Y Huang","year":"2010","unstructured":"Huang Y et al (2010) In vitro and in vivo performance of a dual drug-eluting stent (DDES). Biomaterials 31:4382\u20134391","journal-title":"Biomaterials"},{"key":"97_CR67","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1161\/hc3101.092214","volume":"104","author":"C-W Hwang","year":"2001","unstructured":"Hwang C-W, Wu D, Edelman ER (2001) Physiological transport forces govern drug distribution for stent-based delivery. Circulation 104:600\u2013605","journal-title":"Circulation"},{"key":"97_CR68","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0142-9612(97)80009-9","volume":"18","author":"SE Ibim","year":"1997","unstructured":"Ibim SE, Ambrosio AM, Kwon MS, El-Amin SF, Allcock HR, Laurencin CT (1997) Novel polyphosphazene\/poly (lactide-co-glycolide) blends: miscibility and degradation studies. Biomaterials 18:1565\u20131569","journal-title":"Biomaterials"},{"key":"97_CR69","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/eurheartj\/eht542","volume":"35","author":"J Iqbal","year":"2013","unstructured":"Iqbal J, Onuma Y, Ormiston J, Abizaid A, Waksman R, Serruys P (2013) Bioresorbable scaffolds: rationale, current status, challenges, and future. Eur Heart J 35:765\u2013776","journal-title":"Eur Heart J"},{"key":"97_CR70","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1016\/S0142-9612(00)00115-0","volume":"21","author":"RA Jain","year":"2000","unstructured":"Jain RA (2000) The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide)(PLGA) devices. Biomaterials 21:2475\u20132490","journal-title":"Biomaterials"},{"key":"97_CR71","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1021\/acsbiomaterials.7b00215","volume":"3","author":"W Jiang","year":"2017","unstructured":"Jiang W, Tian Q, Vuong T, Shashaty M, Gopez C, Sanders T, Liu H (2017) Comparison study on four biodegradable polymer coatings for controlling magnesium degradation and human endothelial cell adhesion and spreading. ACS Biomater Sci Eng 3:936\u2013950","journal-title":"ACS Biomater Sci Eng"},{"key":"97_CR72","doi-asserted-by":"publisher","first-page":"375103","DOI":"10.1088\/0957-4484\/24\/37\/375103","volume":"24","author":"I Johnson","year":"2013","unstructured":"Johnson I, Akari K, Liu H (2013) Nanostructured hydroxyapatite\/poly (lactic-co-glycolic acid) composite coating for controlling magnesium degradation in simulated body fluid. Nanotechnology 24:375103","journal-title":"Nanotechnology"},{"key":"97_CR73","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","volume":"48","author":"M Joner","year":"2006","unstructured":"Joner M et al (2006) Pathology of drug-eluting stents in humans. J Am Coll Cardiol 48:193\u2013202","journal-title":"J Am Coll Cardiol"},{"key":"97_CR74","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/S0140-6736(11)61715-7","volume":"378","author":"P Jungebluth","year":"2011","unstructured":"Jungebluth P, Alici E, Baiguera S, Le Blanc K, Blomberg P, Bozoky B, Crowley C, Einarsson O, Grinnemo KH, Gudbjartsson T et al (2011) Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study. Lancet 378:1997\u20132004","journal-title":"Lancet"},{"key":"97_CR75","first-page":"529","volume":"7","author":"S Kakade","year":"2013","unstructured":"Kakade S, Mani G (2013) A comparative study of the effects of vitamin C, sirolimus, and paclitaxel on the growth of endothelial and smooth muscle cells for cardiovascular medical device applications. Drug Design Dev Therapy 7:529","journal-title":"Drug Design Dev Therapy"},{"key":"97_CR76","first-page":"1586","volume":"8","author":"H Kawamoto","year":"2015","unstructured":"Kawamoto H et al (2015) Drug-coated balloons versus second-generation drug-eluting stents for the management of recurrent multimetal-layered in-stent restenosis. JACC 8:1586\u20131594","journal-title":"JACC"},{"key":"97_CR77","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1161\/CIRCULATIONAHA.116.021539","volume":"134","author":"DJ Kereiakes","year":"2016","unstructured":"Kereiakes DJ, Onuma Y, Serruys PW, Stone GW (2016) Bioresorbable vascular scaffolds for coronary revascularization. Circulation 134:168\u2013182","journal-title":"Circulation"},{"issue":"7","key":"97_CR78","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1007\/s12221-018-8037-y","volume":"19","author":"M Khashi","year":"2018","unstructured":"Khashi M, Hassanajili S, Golestaneh SM (2018) Electrospun poly-lactic acid\/chitosan nanofibers loaded with paclitaxel for coating of a prototype polymeric stent. Fibers Polymers J 19(7):1444\u20131453","journal-title":"Fibers Polymers J"},{"key":"97_CR79","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.porgcoat.2014.07.013","volume":"78","author":"JM Kim","year":"2015","unstructured":"Kim JM et al (2015) A method for coating fucoidan onto bare metal stent and in vivo evaluation. Prog Org Coat 78:348\u2013356","journal-title":"Prog Org Coat"},{"issue":"47","key":"97_CR80","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1093\/eurheartj\/ehv435","volume":"36","author":"T Kimura","year":"2015","unstructured":"Kimura T, Kozuma K, Tanabe K, Nakamura S, Yamane M, Muramatsu T, Saito S, Yajima J, Hagiwara N, Mitsudo K, Popma JJ, Serruys PW, Onuma Y, Ying S, Cao S, Staehr P, Cheong WF, Kusano H, Stone GW (2015) A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan. Eur Heart J 36(47):3332\u20133342. https:\/\/doi.org\/10.1093\/eurheartj\/ehv435","journal-title":"Eur Heart J"},{"key":"97_CR81","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1586\/17434440.2015.1080119","volume":"12","author":"V Ko\u010dka","year":"2015","unstructured":"Ko\u010dka V, Tou\u0161ek P, Widimsk\u00fd P (2015) Absorb bioresorbable stents for the treatment of coronary artery disease. Expert Rev Med Devices 12:545\u2013557","journal-title":"Expert Rev Med Devices"},{"key":"97_CR82","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1586\/17434440.2.6.667","volume":"2","author":"J Kohn","year":"2005","unstructured":"Kohn J, Zeltinger J (2005) Degradable, drug-eluting stents: a new frontier for the treatment of coronary artery disease. Expert Rev Med Devices 2:667\u2013671","journal-title":"Expert Rev Med Devices"},{"key":"97_CR83","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1089\/end.2007.0047","volume":"22","author":"A Kotsar","year":"2008","unstructured":"Kotsar A et al (2008) A new biodegradable braided self-expandable PLGA prostatic stent: an experimental study in the rabbit. J Endourol 22:1065\u20131070","journal-title":"J Endourol"},{"key":"97_CR84","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/jbm.b.30974","volume":"85","author":"A Kraitzer","year":"2008","unstructured":"Kraitzer A, Kloog Y, Zilberman M (2008) Approaches for prevention of restenosis. J Biomed Mater Res Part B 85:583\u2013603","journal-title":"J Biomed Mater Res Part B"},{"key":"97_CR85","doi-asserted-by":"publisher","first-page":"11511","DOI":"10.1021\/la301636z","volume":"28","author":"S Lancaster","year":"2012","unstructured":"Lancaster S, Kakade S, Mani G (2012) Microrough cobalt\u2013chromium alloy surfaces for paclitaxel delivery: preparation, characterization, and in vitro drug release studies. Langmuir 28:11511\u201311526","journal-title":"Langmuir"},{"key":"97_CR86","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1016\/0009-2509(95)00226-X","volume":"50","author":"R Langer","year":"1995","unstructured":"Langer R (1995) Biomaterials and biomedical engineering. Chem Eng Sci 50:4109\u20134121","journal-title":"Chem Eng Sci"},{"key":"97_CR87","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1002\/aic.690491202","volume":"49","author":"R Langer","year":"2003","unstructured":"Langer R, Peppas NA (2003) Advances in biomaterials, drug delivery, and bionanotechnology. AIChE J 49:2990\u20133006","journal-title":"AIChE J"},{"key":"97_CR88","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00059-008-3080-x","volume":"33","author":"P Lanzer","year":"2008","unstructured":"Lanzer P, Sternberg K, Schmitz K-P, Kolodgie F, Nakazawa G, Virmani R (2008) Drug-eluting coronary stent very late thrombosis revisited. Herz 33:334\u2013342","journal-title":"Herz"},{"key":"97_CR89","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/088391159801300102","volume":"13","author":"Y Lemmouchi","year":"1998","unstructured":"Lemmouchi Y, Schacht E, Dejardin S (1998) Biodegradable poly [(amino acid ester) phosphazenes] for biomedical applications. J Bioact Compat Polymers 13:4\u201318","journal-title":"J Bioact Compat Polymers"},{"key":"97_CR90","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1126\/science.1066102","volume":"296","author":"A Lendlein","year":"2002","unstructured":"Lendlein A, Langer R (2002) Biodegradable, elastic shape-memory polymers for potential biomedical applications. Science 296:1673\u20131676","journal-title":"Science"},{"key":"97_CR91","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0169-409X(88)90019-1","volume":"1","author":"K Leong","year":"1988","unstructured":"Leong K, Langer R (1988) Polymeric controlled drug delivery. Adv Drug Deliv Rev 1:199\u2013233","journal-title":"Adv Drug Deliv Rev"},{"key":"97_CR92","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/jbm.b.31420","volume":"91","author":"Y Levy","year":"2009","unstructured":"Levy Y, Mandler D, Weinberger J, Domb AJ (2009a) Evaluation of drug-eluting stents\u2019 coating durability\u2014clinical and regulatory implications. J Biomed Mater Res Part B 91:441\u2013451","journal-title":"J Biomed Mater Res Part B"},{"key":"97_CR93","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/jbm.b.31461","volume":"91","author":"Y Levy","year":"2009","unstructured":"Levy Y, Tal N, Tzemach G, Weinberger J, Domb AJ, Mandler D (2009b) Drug-eluting stent with improved durability and controllability properties, obtained via electrocoated adhesive promotion layer. J Biomed Mater Res Part B 91:819\u2013830","journal-title":"J Biomed Mater Res Part B"},{"key":"97_CR94","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/jbm.a.31999","volume":"89","author":"QL Li","year":"2009","unstructured":"Li QL et al (2009) Anticoagulant surface modification of titanium via layer-by-layer assembly of collagen and sulfated chitosan multilayers. J Biomed Mater Res Part A 89:575\u2013584","journal-title":"J Biomed Mater Res Part A"},{"key":"97_CR95","doi-asserted-by":"publisher","first-page":"6038","DOI":"10.1007\/s10853-010-4688-9","volume":"45","author":"J Li","year":"2010","unstructured":"Li J, Cao P, Zhang X, Zhang S, He Y (2010) In vitro degradation and cell attachment of a PLGA coated biodegradable Mg\u20136Zn based alloy. J Mater Sci 45:6038\u20136045","journal-title":"J Mater Sci"},{"key":"97_CR96","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1021\/bm101468v","volume":"12","author":"G Li","year":"2011","unstructured":"Li G, Yang P, Liao Y, Huang N (2011) Tailoring of the titanium surface by immobilization of heparin\/fibronectin complexes for improving blood compatibility and endothelialization: an in vitro study. Biomacromol 12:1155\u20131168","journal-title":"Biomacromol"},{"key":"97_CR97","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1007\/s10853-015-8889-0","volume":"50","author":"J Li","year":"2015","unstructured":"Li J, Zhang K, Wu F, He Z, Yang P, Huang N (2015a) Constructing bio-functional layers of hyaluronan and type IV collagen on titanium surface for improving endothelialization. J Mater Sci 50:3226\u20133236","journal-title":"J Mater Sci"},{"key":"97_CR98","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.colsurfb.2015.01.010","volume":"128","author":"J Li","year":"2015","unstructured":"Li J, Zhang K, Wu J, Zhang L, Yang P, Tu Q, Huang N (2015b) Tailoring of the titanium surface by preparing cardiovascular endothelial extracellular matrix layer on the hyaluronic acid micro-pattern for improving biocompatibility. Colloids Surf B 128:201\u2013210","journal-title":"Colloids Surf B"},{"key":"97_CR99","doi-asserted-by":"publisher","first-page":"30343","DOI":"10.1021\/acsami.7b07444","volume":"9","author":"J Li","year":"2017","unstructured":"Li J et al (2017) Controlling molecular weight of hyaluronic acid conjugated on amine-rich surface: toward better multifunctional biomaterials for cardiovascular implants. ACS Appl Mater Interfaces 9:30343\u201330358","journal-title":"ACS Appl Mater Interfaces"},{"key":"97_CR100","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/S0735-1097(96)00584-0","volume":"29","author":"AM Lincoff","year":"1997","unstructured":"Lincoff AM, Furst JG, Ellis SG, Tuch RJ, Topol EJ (1997) Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. J Am Coll Cardiol 29:808\u2013816","journal-title":"J Am Coll Cardiol"},{"key":"97_CR101","first-page":"999","volume":"7","author":"Q Liu","year":"2012","unstructured":"Liu Q, Zhang J, Sun W, Xie QR, Xia W, Gu H (2012) Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells. Int J Nanomed 7:999","journal-title":"Int J Nanomed"},{"key":"97_CR102","doi-asserted-by":"publisher","first-page":"8729","DOI":"10.1021\/am5015309","volume":"6","author":"T Liu","year":"2014","unstructured":"Liu T et al (2014) Surface modification with dopamine and heparin\/poly-l-lysine nanoparticles provides a favorable release behavior for the healing of vascular stent lesions. ACS Appl Mater Interfaces 6:8729\u20138743","journal-title":"ACS Appl Mater Interfaces"},{"key":"97_CR103","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1039\/C6TB03147A","volume":"5","author":"J Liu","year":"2017","unstructured":"Liu J, Wang P, Chu C-C, Xi T (2017) A novel biodegradable and biologically functional arginine-based poly (ester urea urethane) coating for Mg\u2013Zn\u2013Y\u2013Nd alloy: enhancement in corrosion resistance and biocompatibility. J Mater Chem B 5:1787\u20131802","journal-title":"J Mater Chem B"},{"key":"97_CR104","first-page":"376","volume":"74","author":"D Logeart","year":"1997","unstructured":"Logeart D, Prigent-Richard S, Jozefonvicz J, Letourneur D (1997) Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. Comparison with heparin for antiproliferative activity, binding and internalization. Eur J Cell Biol 74:376\u2013384","journal-title":"Eur J Cell Biol"},{"key":"97_CR105","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.colsurfb.2010.10.038","volume":"83","author":"P Lu","year":"2011","unstructured":"Lu P, Fan H, Liu Y, Cao L, Wu X, Xu X (2011) Controllable biodegradability, drug release behavior and hemocompatibility of PTX-eluting magnesium stents. Colloids Surf B 83:23\u201328","journal-title":"Colloids Surf B"},{"key":"97_CR106","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/jbm.a.33066","volume":"97","author":"L Luo","year":"2011","unstructured":"Luo L, Wang G, Li Y, Yin T, Jiang T, Ruan C (2011) Layer-by-layer assembly of chitosan and platelet monoclonal antibody to improve biocompatibility and release character of PLLA coated stent. J Biomed Mater Res Part A 97:423\u2013432","journal-title":"J Biomed Mater Res Part A"},{"key":"97_CR107","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1116\/1.3575530","volume":"6","author":"G Mani","year":"2011","unstructured":"Mani G, Torres N, Oh S (2011) Paclitaxel delivery from cobalt-chromium alloy surfaces using self-assembled monolayers. Biointerphases 6:33\u201342","journal-title":"Biointerphases"},{"key":"97_CR108","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-88-470-2682-7_12","volume-title":"Imaging coronary arteries","author":"E Mariano","year":"2013","unstructured":"Mariano E, Sangiorgi GM, Fioranelli M (2013) Coronary stents. In: Imaging coronary arteries. Springer, New York, pp 101\u2013113"},{"key":"97_CR109","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1021\/ie800886m","volume":"48","author":"EM Mart\u00edn del Valle","year":"2009","unstructured":"del Valle Mart\u00edn EM, Galan MA, Carbonell RG (2009) Drug delivery technologies: the way forward in the new decade. Indus Eng Chem Res 48:2475\u20132486","journal-title":"Indus Eng Chem Res"},{"issue":"2","key":"97_CR110","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/imammb\/dqt025","volume":"32","author":"S McGinty","year":"2014","unstructured":"McGinty S, McKee S, McCormick C, Wheel M (2014) Release mechanism and parameter estimation in drug-eluting stent systems: analytical solutions of drug release and tissue transport. Math Med Biol 32(2):163\u2013186","journal-title":"Math Med Biol"},{"key":"97_CR111","first-page":"30","volume":"5","author":"JC Middleton","year":"1998","unstructured":"Middleton JC, Tipton A (1998) Synthetic biodegradable polymers as medical devices. Med Plast Biomater 5:30\u201339","journal-title":"Med Plast Biomater"},{"key":"97_CR112","first-page":"45","volume":"2","author":"M-C Morice","year":"2006","unstructured":"Morice M-C et al (2006) Direct stenting of de novo coronary stenoses with tacrolimus-eluting versus carbon-coated carbostents. The randomized JUPITER II trial. EuroIntervention 2:45\u201352","journal-title":"EuroIntervention"},{"key":"97_CR113","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/21691401.2014.927879","volume":"44","author":"A Morie","year":"2016","unstructured":"Morie A, Garg T, Goyal AK, Rath G (2016) Nanofibers as novel drug carrier\u2014an overview. Artif Cells Nanomed Biotechnol 44:135\u2013143","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"3","key":"97_CR219","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jcin.2012.10.013","volume":"6","author":"T Muramatsu","year":"2013","unstructured":"Muramatsu T, Onuma Y, Garc\u00eda-Garc\u00eda HM, Farooq V, Bourantas CV, Morel MA, Li X, Veldhof S, Bartorelli A, Whitbourn R, Abizaid A, Serruys PW, ABSORB-EXTEND Investigators (2013) Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORBEXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials. JACC Cardiovasc Interv 6(3):247\u2013257","journal-title":"JACC Cardiovasc Interv"},{"key":"97_CR114","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1002\/app.20687","volume":"93","author":"C Nakafuku","year":"2004","unstructured":"Nakafuku C, Takehisa SY (2004) Glass transition and mechanical properties of PLLA and PDLLA-PGA copolymer blends. J Appl Polym Sci 93:2164\u20132173","journal-title":"J Appl Polym Sci"},{"key":"97_CR115","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1586\/14779072.6.10.1379","volume":"6","author":"G Nakazawa","year":"2008","unstructured":"Nakazawa G, Finn AV, Ladich E, Ribichini F, Coleman L, Kolodgie FD, Virmani R (2008) Drug-eluting stent safety: findings from preclinical studies. Expert Rev Cardiovasc Therapy 6:1379\u20131391","journal-title":"Expert Rev Cardiovasc Therapy"},{"key":"97_CR116","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ijpharm.2004.02.009","volume":"275","author":"K Nam","year":"2004","unstructured":"Nam K, Watanabe J, Ishihara K (2004) Modeling of swelling and drug release behavior of spontaneously forming hydrogels composed of phospholipid polymers. Int J Pharm 275:259\u2013269","journal-title":"Int J Pharm"},{"key":"97_CR117","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40759-017-0028-y","volume":"3","author":"R Naseem","year":"2017","unstructured":"Naseem R, Zhao L, Liu Y, Silberschmidt VV (2017) Experimental and computational studies of poly-l-lactic acid for cardiovascular applications: recent progress. Mech Adv Mater Modern Process 3:13","journal-title":"Mech Adv Mater Modern Process"},{"key":"97_CR118","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.atherosclerosis.2013.12.024","volume":"233","author":"EP Navarese","year":"2014","unstructured":"Navarese EP et al (2014) Short and long-term safety and efficacy of polymer-free vs. durable polymer drug-eluting stents. A comprehensive meta-analysis of randomized trials including 6178 patients. Atherosclerosis 233:224\u2013231","journal-title":"Atherosclerosis"},{"key":"97_CR119","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jacc.2005.07.071","volume":"47","author":"JR Nebeker","year":"2006","unstructured":"Nebeker JR et al (2006) Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 47:175\u2013181","journal-title":"J Am Coll Cardiol"},{"key":"97_CR120","doi-asserted-by":"publisher","first-page":"e76547","DOI":"10.1371\/journal.pone.0076547","volume":"8","author":"TY Nguyen","year":"2013","unstructured":"Nguyen TY, Liew CG, Liu H (2013) An in vitro mechanism study on the proliferation and pluripotency of human embryonic stems cells in response to magnesium degradation. PLoS One 8:e76547","journal-title":"PLoS One"},{"key":"97_CR121","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.stam.2003.09.002","volume":"4","author":"M Niinomi","year":"2003","unstructured":"Niinomi M (2003) Recent research and development in titanium alloys for biomedical applications and healthcare goods. Sci Technol Adv Mater 4:445","journal-title":"Sci Technol Adv Mater"},{"key":"97_CR122","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1002\/1097-0142(19931215)72:12<3599::AID-CNCR2820721209>3.0.CO;2-8","volume":"72","author":"Y Nio","year":"1993","unstructured":"Nio Y et al (1993) Loxiglumide (CR1505), a cholecystokinin antagonist, specifically inhibits the growth of human pancreatic cancer lines xenografted into nude mice. Cancer 72:3599\u20133606","journal-title":"Cancer"},{"key":"97_CR123","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/S0735-1097(88)80046-9","volume":"12","author":"M Nobuyoshi","year":"1988","unstructured":"Nobuyoshi M et al (1988) Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 12:616\u2013623","journal-title":"J Am Coll Cardiol"},{"key":"97_CR124","doi-asserted-by":"publisher","first-page":"19677","DOI":"10.1021\/acsami.7b04626","volume":"9","author":"H Nuhn","year":"2017","unstructured":"Nuhn H, Blanco CE, Desai TA (2017) Nanoengineered stent surface to reduce in-stent restenosis in vivo. ACS Appl Mater Interfaces 9:19677\u201319686","journal-title":"ACS Appl Mater Interfaces"},{"key":"97_CR217","doi-asserted-by":"publisher","first-page":"F15","DOI":"10.4244\/EIJV5IFA3","volume":"5","author":"JP Oberhauser","year":"2009","unstructured":"Oberhauser JP, Hossainy S, Rapoza RJ (2009) Design principles and performance of bioresorbable polymeric vascular scaffolds. EuroIntervention 5:F15\u2013F22","journal-title":"EuroIntervention"},{"key":"97_CR125","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.1021\/mp400231p","volume":"10","author":"B Oh","year":"2013","unstructured":"Oh B, Lee CH (2013) Advanced cardiovascular stent coated with nanofiber. Mol Pharm 10:4432\u20134442","journal-title":"Mol Pharm"},{"key":"97_CR126","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1161\/CIRCULATIONAHA.110.971606","volume":"123","author":"Y Onuma","year":"2011","unstructured":"Onuma Y, Serruys PW (2011) Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization? Circulation 123:779\u2013797","journal-title":"Circulation"},{"key":"97_CR218","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1161\/CIRCINTERVENTIONS.109.859173","volume":"2","author":"JA Ormiston","year":"2009","unstructured":"Ormiston JA, Serruys PW (2009) Bioabsorbable coronary stents. Circ Cardiovasc Interv 2:255\u2013260","journal-title":"Circ Cardiovasc Interv"},{"key":"97_CR127","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/ccd.20895","volume":"69","author":"JA Ormiston","year":"2007","unstructured":"Ormiston JA, Webster MW, Armstrong G (2007) First-in-human implantation of a fully bioabsorbable drug-eluting stent: the BVS poly-l-lactic acid everolimus-eluting coronary stent. Catheter Cardiovasc Interv 69:128\u2013131","journal-title":"Catheter Cardiovasc Interv"},{"key":"97_CR128","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0140-6736(08)60415-8","volume":"371","author":"JA Ormiston","year":"2008","unstructured":"Ormiston JA et al (2008) A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet 371:899\u2013907","journal-title":"Lancet"},{"key":"97_CR129","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000250095","volume":"47","author":"AW Orr","year":"2010","unstructured":"Orr AW, Hastings NE, Blackman BR, Wamhoff BR (2010) Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis. J Vasc Res 47:168\u2013180","journal-title":"J Vasc Res"},{"key":"97_CR130","first-page":"71","volume":"19","author":"Y Otsuka","year":"2007","unstructured":"Otsuka Y, Chronos N, Apkarian RP, Robinson KA (2007) Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: comparison of BiodivYsio, Taxus and Cypher stents. J Invasive Cardiol 19:71\u201376","journal-title":"J Invasive Cardiol"},{"key":"97_CR131","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2214\/ajr.160.3.8430566","volume":"160","author":"JC Palmaz","year":"1993","unstructured":"Palmaz JC (1993) Intravascular stents: tissue-stent interactions and design considerations. AJR Am J Roentgenol 160:613\u2013618","journal-title":"AJR Am J Roentgenol"},{"key":"97_CR132","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1148\/radiology.164.3.2956628","volume":"164","author":"JC Palmaz","year":"1987","unstructured":"Palmaz JC et al (1987) Normal and stenotic renal arteries: experimental balloon-expandable intraluminal stenting. Radiology 164:705\u2013708","journal-title":"Radiology"},{"key":"97_CR133","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.2174\/138161210794454897","volume":"16","author":"T Parker","year":"2010","unstructured":"Parker T, Dave V, Falotico R (2010) Polymers for drug eluting stents. Curr Pharm Des 16:3978\u20133988","journal-title":"Curr Pharm Des"},{"key":"97_CR134","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/0142-9612(96)86738-X","volume":"17","author":"T Peng","year":"1996","unstructured":"Peng T, Gibula P, Goosen MF (1996) Role of polymers in improving the results of stenting in coronary arteries. Biomaterials 17:685\u2013694","journal-title":"Biomaterials"},{"key":"97_CR135","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1021\/bm049477j","volume":"6","author":"P Ping","year":"2005","unstructured":"Ping P, Wang W, Chen X, Jing X (2005) Poly (\u03b5-caprolactone) polyurethane and its shape-memory property. Biomacromol 6:587\u2013592","journal-title":"Biomacromol"},{"key":"97_CR136","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1039\/c1nr10224a","volume":"3","author":"A Popat","year":"2011","unstructured":"Popat A, Hartono SB, Stahr F, Liu J, Qiao SZ, Lu GQM (2011) Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers. Nanoscale 3:2801\u20132818","journal-title":"Nanoscale"},{"key":"97_CR137","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/187152911795945169","volume":"11","author":"A Pourdjabbar","year":"2011","unstructured":"Pourdjabbar A, Hibbert B, Simard T, Ma X, O\u2019Brien RE (2011) Pathogenesis of neointima formation following vascular injury. Cardiovasc Haematol Disord Drug Targets (Formerly Current Drug Targets-Cardiovascular & Hematological Disorders) 11:30\u201339","journal-title":"Cardiovasc Haematol Disord Drug Targets (Formerly Current Drug Targets-Cardiovascular & Hematological Disorders)"},{"key":"97_CR138","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1115\/1.1613674","volume":"125","author":"P Prendergast","year":"2003","unstructured":"Prendergast P, Lally C, Daly S, Reid A, Lee T, Quinn D, Dolan F (2003) Analysis of prolapse in cardiovascular stents: a constitutive equation for vascular tissue and finite-element modelling. J Biomech Eng 125:692\u2013699","journal-title":"J Biomech Eng"},{"key":"97_CR139","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/bip.360320418","volume":"32","author":"S Pulapura","year":"1992","unstructured":"Pulapura S, Kohn J (1992) Tyrosine-derived polycarbonates: backbone-modified \u201cpseudo\u201d-poly (amino acids) designed for biomedical applications. Biopolymers 32:411\u2013417","journal-title":"Biopolymers"},{"key":"97_CR140","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/0142-9612(90)90025-L","volume":"11","author":"S Pulapura","year":"1990","unstructured":"Pulapura S, Li C, Kohn J (1990) Structure-property relationships for the design of polyiminocarbonates. Biomaterials 11:666\u2013678","journal-title":"Biomaterials"},{"key":"97_CR141","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jacc.2014.12.017","volume":"65","author":"S Puricel","year":"2015","unstructured":"Puricel S et al (2015) Comparison of everolimus-and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds. J Am Coll Cardiol 65:791\u2013801","journal-title":"J Am Coll Cardiol"},{"key":"97_CR142","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.surfcoat.2013.02.008","volume":"233","author":"P Qi","year":"2013","unstructured":"Qi P, Maitz MF, Huang N (2013) Surface modification of cardiovascular materials and implants. Surf Coat Technol 233:80\u201390","journal-title":"Surf Coat Technol"},{"key":"97_CR143","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1021\/acsami.7b15206","volume":"10","author":"Y Qi","year":"2017","unstructured":"Qi Y et al (2017) Strategy of metal\u2013polymer composite stent to accelerate biodegradation of iron-based biomaterials. ACS Appl Mater Interfaces 10:182\u2013192","journal-title":"ACS Appl Mater Interfaces"},{"key":"97_CR144","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/S0140-6736(13)61088-0","volume":"383","author":"AI Qureshi","year":"2014","unstructured":"Qureshi AI, Caplan LR (2014) Intracranial atherosclerosis. Lancet 383:984\u2013998","journal-title":"Lancet"},{"key":"97_CR145","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/0735-1097(91)90685-3","volume":"18","author":"ST Rab","year":"1991","unstructured":"Rab ST, King SB, Roubin GS, Carlin S, Hearn JA, Douglas JS (1991) Coronary aneurysms after stent placement: a suggestion of altered vessel wall healing in the presence of anti-inflammatory agents. J Am Coll Cardiol 18:1524\u20131528","journal-title":"J Am Coll Cardiol"},{"key":"97_CR146","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/bmb\/59.1.227","volume":"59","author":"E Regar","year":"2001","unstructured":"Regar E, Sianos G, Serruys P (2001) Stent development and local drug delivery. Br Med Bull 59:227\u2013248","journal-title":"Br Med Bull"},{"key":"97_CR147","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1053\/euhj.2001.2892","volume":"22","author":"B Rensing","year":"2001","unstructured":"Rensing B et al (2001) Coronary restenosis elimination with a sirolimus eluting stent; First European human experience with 6-month angiographic and intravascular ultrasonic follow-up. Eur Heart J 22:2125\u20132130","journal-title":"Eur Heart J"},{"key":"97_CR148","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.micromeso.2011.04.022","volume":"145","author":"JM Rosenholm","year":"2011","unstructured":"Rosenholm JM, Zhang J, Sun W, Gu H (2011) Large-pore mesoporous silica-coated magnetite core-shell nanocomposites and their relevance for biomedical applications. Microporous Mesoporous Mater 145:14\u201320","journal-title":"Microporous Mesoporous Mater"},{"key":"97_CR149","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev.cb.04.110188.001305","volume":"4","author":"E Ruoslahti","year":"1988","unstructured":"Ruoslahti E (1988) Structure and biology of proteoglycans. Annu Rev Cell Biol 4:229\u2013255","journal-title":"Annu Rev Cell Biol"},{"key":"97_CR150","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12265-009-9105-x","volume":"2","author":"SK Ryu","year":"2009","unstructured":"Ryu SK, Mahmud E, Tsimikas S (2009) Estrogen-eluting stents. J Cardiovasc Trans Res 2:240\u2013244","journal-title":"J Cardiovasc Trans Res"},{"key":"97_CR151","doi-asserted-by":"publisher","first-page":"40291","DOI":"10.1038\/srep40291","volume":"7","author":"YE Saleh","year":"2017","unstructured":"Saleh YE, Gepreel MA, Allam NK (2017) Functional nanoarchitectures for enhanced drug eluting stents. Sci Rep 7:40291","journal-title":"Sci Rep"},{"key":"97_CR152","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.bsbt.2015.08.001","volume":"1","author":"M Santos","year":"2015","unstructured":"Santos M, Bilek M, Wise S (2015) Plasma-synthesised carbon-based coatings for cardiovascular applications. Biosurf Biotribol 1:146\u2013160","journal-title":"Biosurf Biotribol"},{"key":"97_CR153","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0735-1097(91)90952-6","volume":"17","author":"RA Schatz","year":"1991","unstructured":"Schatz RA et al (1991) Clinical experience with the Palmaz-Schatz coronary stent. J Am Coll Cardiol 17:155\u2013159","journal-title":"J Am Coll Cardiol"},{"key":"97_CR154","doi-asserted-by":"publisher","first-page":"e6409","DOI":"10.1136\/bmj.e6409","volume":"345","author":"LL Schierbeck","year":"2012","unstructured":"Schierbeck LL et al (2012) Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ 345:e6409","journal-title":"BMJ"},{"key":"97_CR155","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/ccd.21832","volume":"73","author":"W Schmidt","year":"2009","unstructured":"Schmidt W, Lanzer P, Behrens P, Topoleski L, Schmitz KP (2009) A comparison of the mechanical performance characteristics of seven drug-eluting stent systems. Catheter Cardiovas Interv 73:350\u2013360","journal-title":"Catheter Cardiovas Interv"},{"key":"97_CR156","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1021\/ma981517m","volume":"32","author":"K Schwach-Abdellaoui","year":"1999","unstructured":"Schwach-Abdellaoui K, Heller J, Gurny R (1999) Hydrolysis and erosion studies of autocatalyzed poly (ortho esters) containing lactoyl\u2013lactyl acid dimers. Macromolecules 32:301\u2013307","journal-title":"Macromolecules"},{"key":"97_CR157","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1056\/NEJM199408253310801","volume":"331","author":"PW Serruys","year":"1994","unstructured":"Serruys PW et al (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331:489\u2013495","journal-title":"N Engl J Med"},{"key":"97_CR158","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1056\/NEJMra051091","volume":"354","author":"PW Serruys","year":"2006","unstructured":"Serruys PW, Kutryk MJ, Ong AT (2006) Coronary-artery stents. N Engl J Med 354:483\u2013495","journal-title":"N Engl J Med"},{"key":"97_CR159","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S0140-6736(09)60325-1","volume":"373","author":"PW Serruys","year":"2009","unstructured":"Serruys PW et al (2009) A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 373:897\u2013910","journal-title":"Lancet"},{"key":"97_CR160","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/eurheartj\/ehr384","volume":"33","author":"PW Serruys","year":"2011","unstructured":"Serruys PW, Garcia-Garcia HM, Onuma Y (2011a) From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade? Eur Heart J 33:16\u201325","journal-title":"Eur Heart J"},{"key":"97_CR161","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.jacc.2011.05.050","volume":"58","author":"PW Serruys","year":"2011","unstructured":"Serruys PW et al (2011b) Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. J Am Coll Cardiol 58:1578\u20131588","journal-title":"J Am Coll Cardiol"},{"key":"97_CR162","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1002\/jps.20957","volume":"96","author":"T Sharkawi","year":"2007","unstructured":"Sharkawi T, Cornhill F, Lafont A, Sabaria P, Vert M (2007) Intravascular bioresorbable polymeric stents: a potential alternative to current drug eluting metal stents. J Pharm Sci 96:2829\u20132837","journal-title":"J Pharm Sci"},{"key":"97_CR163","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1056\/NEJM198703193161201","volume":"316","author":"U Sigwart","year":"1987","unstructured":"Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L (1987) Intravascular stents to prevent occlusion and re-stenosis after transluminal angioplasty. N Engl J Med 316:701\u2013706","journal-title":"N Engl J Med"},{"key":"97_CR164","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1161\/01.CIR.78.5.1121","volume":"78","author":"U Sigwart","year":"1988","unstructured":"Sigwart U, Urban P, Golf S, Kaufmann U, Imbert C, Fischer A, Kappenberger L (1988) Emergency stenting for acute occlusion after coronary balloon angioplasty. Circulation 78:1121\u20131127","journal-title":"Circulation"},{"key":"97_CR165","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cjca.2013.09.012","volume":"30","author":"T Simard","year":"2014","unstructured":"Simard T, Hibbert B, Ramirez FD, Froeschl M, Chen Y-X, O\u2019Brien ER (2014) The evolution of coronary stents: a brief review. Can J Cardiol 30:35\u201345","journal-title":"Can J Cardiol"},{"key":"97_CR166","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1021\/ma00009a025","volume":"24","author":"A Staubli","year":"1991","unstructured":"Staubli A, Mathiowitz E, Lucarelli M, Langer R (1991) Characterization of hydrolytically degradable amino acid containing poly (anhydride-co-imides). Macromolecules 24:2283\u20132290","journal-title":"Macromolecules"},{"key":"97_CR167","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1001\/jama.294.10.1215","volume":"294","author":"GW Stone","year":"2005","unstructured":"Stone GW et al (2005) Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 294:1215\u20131223","journal-title":"JAMA"},{"key":"97_CR168","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1163\/156856292X00402","volume":"3","author":"J Tamada","year":"1992","unstructured":"Tamada J, Langer R (1992) The development of polyanhydrides for drug delivery applications. J Biomater Sci Polym Edit 3:315\u2013353","journal-title":"J Biomater Sci Polym Edit"},{"key":"97_CR169","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1161\/01.CIR.102.4.399","volume":"102","author":"H Tamai","year":"2000","unstructured":"Tamai H et al (2000) Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 102:399\u2013404","journal-title":"Circulation"},{"key":"97_CR170","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.tibtech.2012.05.004","volume":"30","author":"A Tan","year":"2012","unstructured":"Tan A, Alavijeh MS, Seifalian AM (2012) Next generation stent coatings: convergence of biotechnology and nanotechnology. Trends Biotechnol 30:406\u2013409","journal-title":"Trends Biotechnol"},{"key":"97_CR171","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1559-4106-8-23","volume":"8","author":"A Tan","year":"2013","unstructured":"Tan A et al (2013) Surface modification of a polyhedral oligomeric silsesquioxane poly (carbonate-urea) urethane (POSS-PCU) nanocomposite polymer as a stent coating for enhanced capture of endothelial progenitor cells. Biointerphases 8:23","journal-title":"Biointerphases"},{"key":"97_CR172","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0733-8651(18)30086-9","volume":"12","author":"JF Tanguay","year":"1994","unstructured":"Tanguay JF, Zidar J, Phillips H 3rd, Stack R (1994) Current status of biodegradable stents. Cardiol Clin 12:699\u2013713","journal-title":"Cardiol Clin"},{"key":"97_CR173","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1021\/la501448h","volume":"30","author":"E Thiruppathi","year":"2014","unstructured":"Thiruppathi E, Mani G (2014) Vitamin-c delivery from cocr alloy surfaces using polymer-free and polymer-based platforms for cardiovascular stent applications. Langmuir 30:6237\u20136249","journal-title":"Langmuir"},{"key":"97_CR174","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0021-9290(03)00259-8","volume":"37","author":"A Tortoriello","year":"2004","unstructured":"Tortoriello A, Pedrizzetti G (2004) Flow-tissue interaction with compliance mismatch in a model stented artery. J Biomech 37:1\u201311","journal-title":"J Biomech"},{"key":"97_CR175","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1517\/17425247.4.3.287","volume":"4","author":"I Tsujino","year":"2007","unstructured":"Tsujino I, Ako J, Honda Y, Fitzgerald PJ (2007) Drug delivery via nano-, micro and macroporous coronary stent surfaces. Expert Opin Drug Deliv 4:287\u2013295","journal-title":"Expert Opin Drug Deliv"},{"key":"97_CR176","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00059-004-2561-9","volume":"29","author":"SM Tugtekin","year":"2004","unstructured":"Tugtekin SM, Kappert U, Jung F, Park J-W, Knaut M (2004) Do drug-eluting stents influence the spectrum of coronary artery bypass surgery? Herz 29:201","journal-title":"Herz"},{"key":"97_CR177","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1089\/ten.tea.2008.0405","volume":"15","author":"BE Uygun","year":"2009","unstructured":"Uygun BE, Stojsih SE, Matthew HW (2009) Effects of immobilized glycosaminoglycans on the proliferation and differentiation of mesenchymal stem cells. Tissue Eng Part A 15:3499\u20133512","journal-title":"Tissue Eng Part A"},{"key":"97_CR178","first-page":"403","volume-title":"Coronary stent coatings (Appendix E) handbook of coronary stents","author":"H Beuskeom van","year":"2000","unstructured":"van Beuskeom H, Vander Giessen W, Serruys P, Kutryk M (2000) Coronary stent coatings (Appendix E) handbook of coronary stents, 3rd edn. Martin Dunitz Ltd, London, pp 403\u2013419","edition":"3"},{"key":"97_CR179","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/00019501-199207000-00014","volume":"3","author":"WJ Giessen van der","year":"1992","unstructured":"van der Giessen WJ, van Beusekom HM, van Houten CD, van Woerkens LJ, Verdouw PD, Serruys PW (1992) Coronary stenting with polymer-coated and uncoated self-expanding endoprostheses in pigs. Coron Artery Dis 3:631\u2013640","journal-title":"Coron Artery Dis"},{"key":"97_CR180","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1161\/01.CIR.94.7.1690","volume":"94","author":"WJ Giessen Van Der","year":"1996","unstructured":"Van Der Giessen WJ et al (1996) Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 94:1690\u20131697","journal-title":"Circulation"},{"key":"97_CR181","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/jbm.10466","volume":"63","author":"M Dijk Van","year":"2002","unstructured":"Van Dijk M, Tunc D, Smit T, Higham P, Burger E, Wuisman P (2002) In vitro and in vivo degradation of bioabsorbable PLLA spinal fusion cages. J Biomed Mater Res 63:752\u2013759","journal-title":"J Biomed Mater Res"},{"key":"97_CR182","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.biomaterials.2005.09.002","volume":"27","author":"SS Venkatraman","year":"2006","unstructured":"Venkatraman SS, Tan LP, Joso JFD, Boey YCF, Wang X (2006) Biodegradable stents with elastic memory. Biomaterials 27:1573\u20131578","journal-title":"Biomaterials"},{"key":"97_CR183","unstructured":"Venkatraman S, Boey YC, Khanolkar L (2018) U.S. Patent No. 9,987,399. U.S. Patent and Trademark Office, Washington, DC"},{"key":"97_CR184","first-page":"155","volume":"166","author":"M Vert","year":"1989","unstructured":"Vert M (1989) Bioresorbable polymers for temporary therapeutic applications. Macromol Mater Eng 166:155\u2013168","journal-title":"Macromol Mater Eng"},{"key":"97_CR185","doi-asserted-by":"publisher","first-page":"F9","DOI":"10.4244\/EIJV5IFA2","volume":"5","author":"M Vert","year":"2009","unstructured":"Vert M (2009) Bioabsorbable polymers in medicine: an overview. EuroIntervention 5:F9\u2013F14","journal-title":"EuroIntervention"},{"key":"97_CR186","first-page":"432","volume":"3","author":"M Vert","year":"1992","unstructured":"Vert M, Li S, Spenlehauer G, Gu\u00e9rin P (1992) Bioresorbability and biocompatibility of aliphatic polyesters. J Mater Sci 3:432\u2013446","journal-title":"J Mater Sci"},{"key":"97_CR187","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jmbbm.2010.12.006","volume":"4","author":"A Vieira","year":"2011","unstructured":"Vieira A, Vieira J, Ferra J, Magalh\u00e3es F, Guedes R, Marques A (2011) Mechanical study of PLA\u2013PCL fibers during in vitro degradation. J Mech Behav Biomed Mater 4:451\u2013460","journal-title":"J Mech Behav Biomed Mater"},{"key":"97_CR188","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1161\/01.CIR.0000116202.41966.D4","volume":"109","author":"R Virmani","year":"2004","unstructured":"Virmani R et al (2004a) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent. Circulation 109:701\u2013705","journal-title":"Circulation"},{"key":"97_CR189","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1541-9215.2004.03632.x","volume":"2","author":"R Virmani","year":"2004","unstructured":"Virmani R, Kolodgie FD, Farb A (2004b) Drug-eluting stents: are they really safe? Am Heart Hosp J 2:85\u201388","journal-title":"Am Heart Hosp J"},{"key":"97_CR190","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1002\/smll.200901789","volume":"6","author":"JL Vivero-Escoto","year":"2010","unstructured":"Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VSY (2010) Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small 6:1952\u20131967","journal-title":"Small"},{"key":"97_CR191","doi-asserted-by":"publisher","first-page":"F28","DOI":"10.4244\/EIJV5IFA5","volume":"5","author":"M Vorpahl","year":"2009","unstructured":"Vorpahl M, Finn AV, Nakano M, Virmani R (2009) The bioabsorption process: tissue and cellular mechanisms and outcomes. EuroIntervention 5:F28. https:\/\/doi.org\/10.4244\/EIJV5IFA5","journal-title":"EuroIntervention"},{"key":"97_CR192","first-page":"70","volume":"18","author":"R Waksman","year":"2006","unstructured":"Waksman R (2006) Biodegradable stents: they do their job and disappear. J Invasive Cardiol 18:70\u201374","journal-title":"J Invasive Cardiol"},{"key":"97_CR193","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1540-8183.2007.00319.x","volume":"21","author":"R Waksman","year":"2008","unstructured":"Waksman R, Pakala R, Baffour R, Seabron R, Hellinga D, Tio FO (2008) Short-term effects of biocorrodible iron stents in porcine coronary arteries. J Interv Cardiol 21:15\u201320","journal-title":"J Interv Cardiol"},{"key":"97_CR194","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/jbm.a.34339","volume":"101","author":"H Wang","year":"2013","unstructured":"Wang H et al (2013a) Biofunctionalization of titanium surface with multilayer films modified by heparin-VEGF-fibronectin complex to improve endothelial cell proliferation and blood compatibility. J Biomed Mater Res Part A 101:413\u2013420","journal-title":"J Biomed Mater Res Part A"},{"key":"97_CR195","doi-asserted-by":"publisher","first-page":"10337","DOI":"10.1021\/am403365j","volume":"5","author":"Y Wang","year":"2013","unstructured":"Wang Y, Zhang W, Zhang J, Sun W, Zhang R, Gu H (2013b) Fabrication of a novel polymer-free nanostructured drug-eluting coating for cardiovascular stents. ACS Appl Mater Interfaces 5:10337\u201310345","journal-title":"ACS Appl Mater Interfaces"},{"key":"97_CR196","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.pcad.2015.08.011","volume":"58","author":"SA Wayangankar","year":"2015","unstructured":"Wayangankar SA, Ellis SG (2015) Bioresorbable stents: is this where we are headed? Prog Cardiovasc Dis 58:342\u2013355","journal-title":"Prog Cardiovasc Dis"},{"key":"97_CR197","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1161\/01.ATV.0000157579.52566.ee","volume":"25","author":"R Wessely","year":"2005","unstructured":"Wessely R et al (2005) Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating. Arterioscler Thromb Vasc Biol 25:748\u2013753","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"97_CR198","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1016\/j.jacc.2014.09.041","volume":"64","author":"J Wiebe","year":"2014","unstructured":"Wiebe J, Nef HM, Hamm CW (2014) Current status of bioresorbable scaffolds in the treatment of coronary artery disease. J Am Coll Cardiol 64:2541\u20132551","journal-title":"J Am Coll Cardiol"},{"key":"97_CR199","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ccd.22347","volume":"75","author":"M Wiemer","year":"2010","unstructured":"Wiemer M, Butz T, Schmidt W, Schmitz KP, Horstkotte D, Langer C (2010) Scanning electron microscopic analysis of different drug eluting stents after failed implantation: from nearly undamaged to major damaged polymers. Catheter Cardiovasc Interv 75:905\u2013911","journal-title":"Catheter Cardiovasc Interv"},{"key":"97_CR200","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.actbio.2015.07.017","volume":"23","author":"F Witte","year":"2015","unstructured":"Witte F (2015) Reprint of: the history of biodegradable magnesium implants: a review. Acta Biomater 23:S28\u2013S40","journal-title":"Acta Biomater"},{"key":"97_CR201","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/j.biomaterials.2009.11.111","volume":"31","author":"HM Wong","year":"2010","unstructured":"Wong HM, Yeung KW, Lam KO, Tam V, Chu PK, Luk KD, Cheung KM (2010) A biodegradable polymer-based coating to control the performance of magnesium alloy orthopaedic implants. Biomaterials 31:2084\u20132096","journal-title":"Biomaterials"},{"key":"97_CR202","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1021\/acsami.5b07427","volume":"8","author":"F Wu","year":"2015","unstructured":"Wu F, Li J, Zhang K, He Z, Yang P, Zou D, Huang N (2015) Multifunctional coating based on hyaluronic acid and dopamine conjugate for potential application on surface modification of cardiovascular implanted devices. ACS Appl Mater Interfaces 8:109\u2013121","journal-title":"ACS Appl Mater Interfaces"},{"key":"97_CR203","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/j.biomaterials.2007.01.030","volume":"28","author":"CM Yakacki","year":"2007","unstructured":"Yakacki CM, Shandas R, Lanning C, Rech B, Eckstein A, Gall K (2007) Unconstrained recovery characterization of shape-memory polymer networks for cardiovascular applications. Biomaterials 28:2255\u20132263","journal-title":"Biomaterials"},{"key":"97_CR204","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/S0735-1097(98)00312-X","volume":"32","author":"T Yamawaki","year":"1998","unstructured":"Yamawaki T et al (1998) Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo. J Am Coll Cardiol 32:780\u2013786","journal-title":"J Am Coll Cardiol"},{"key":"97_CR205","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0720-048X(91)90022-N","volume":"13","author":"X Yang","year":"1991","unstructured":"Yang X, Manninen H, Matsi P, Soimakallio S (1991) Percutaneous endovascular stenting: development, investigation and application. Eur J Radiol 13:161\u2013173","journal-title":"Eur J Radiol"},{"key":"97_CR206","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.1016\/j.biomaterials.2012.06.055","volume":"33","author":"Z Yang","year":"2012","unstructured":"Yang Z, Tu Q, Wang J, Huang N (2012) The role of heparin binding surfaces in the direction of endothelial and smooth muscle cell fate and re-endothelialization. Biomaterials 33:6615\u20136625","journal-title":"Biomaterials"},{"key":"97_CR207","doi-asserted-by":"publisher","first-page":"10985","DOI":"10.1021\/am4032295","volume":"5","author":"C-S Yang","year":"2013","unstructured":"Yang C-S, Wu H-C, Sun J-S, Hsiao H-M, Wang T-W (2013) Thermo-induced shape-memory PEG-PCL copolymer as a dual-drug-eluting biodegradable stent. ACS Appl Mater Interfaces 5:10985\u201310994","journal-title":"ACS Appl Mater Interfaces"},{"key":"97_CR208","doi-asserted-by":"publisher","first-page":"14608","DOI":"10.1021\/am503925r","volume":"6","author":"Y Yang","year":"2014","unstructured":"Yang Y et al (2014) Mussel-inspired one-step adherent coating rich in amine groups for covalent immobilization of heparin: hemocompatibility, growth behaviors of vascular cells, and tissue response. ACS Appl Mater Interfaces 6:14608\u201314620","journal-title":"ACS Appl Mater Interfaces"},{"key":"97_CR209","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1039\/C4TB01236D","volume":"3","author":"Y Yang","year":"2015","unstructured":"Yang Y et al (2015) A biocompatible and functional adhesive amine-rich coating based on dopamine polymerization. J Mater Chem B 3:72\u201381","journal-title":"J Mater Chem B"},{"key":"97_CR210","doi-asserted-by":"publisher","first-page":"29280","DOI":"10.1021\/acsami.6b09375","volume":"8","author":"S Yu","year":"2016","unstructured":"Yu S, Gao Y, Mei X, Ren T, Liang S, Mao Z, Gao C (2016) Preparation of an arg-glu-asp-val peptide density gradient on hyaluronic acid-coated poly (\u03b5-caprolactone) film and its influence on the selective adhesion and directional migration of endothelial cells. ACS Appl Mater Interfaces 8:29280\u201329288","journal-title":"ACS Appl Mater Interfaces"},{"key":"97_CR211","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1002\/adfm.200800363","volume":"18","author":"L Zhang","year":"2008","unstructured":"Zhang L et al (2008) Fabrication and size-selective bioseparation of magnetic silica nanospheres with highly ordered periodic mesostructure. Adv Func Mater 18:3203\u20133212","journal-title":"Adv Func Mater"},{"key":"97_CR212","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.matlet.2011.09.086","volume":"67","author":"J Zhang","year":"2012","unstructured":"Zhang J et al (2012) Magnetic mesoporous silica nanospheres as DNA\/drug carrier. Mater Lett 67:379\u2013382","journal-title":"Mater Lett"},{"key":"97_CR213","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00289-010-0266-1","volume":"65","author":"Z Zhou","year":"2010","unstructured":"Zhou Z et al (2010) Biological evaluation of poly-l-lactic acid composite containing bioactive glass. Polym Bull 65:411\u2013423","journal-title":"Polym Bull"},{"key":"97_CR214","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.matlet.2014.06.091","volume":"132","author":"Z Zhou","year":"2014","unstructured":"Zhou Z et al (2014) Fabrication of 3D TiO2 micromesh on silicon surface and its effects on platelet adhesion. Mater Lett 132:149\u2013152","journal-title":"Mater Lett"},{"key":"97_CR215","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.1016\/S0142-9612(02)00215-6","volume":"23","author":"A Zhu","year":"2002","unstructured":"Zhu A, Zhang M, Wu J, Shen J (2002) Covalent immobilization of chitosan\/heparin complex with a photosensitive hetero-bifunctional crosslinking reagent on PLA surface. Biomaterials 23:4657\u20134665","journal-title":"Biomaterials"}],"container-title":["Progress in Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40204-018-0097-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40204-018-0097-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40204-018-0097-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T22:24:41Z","timestamp":1751495081000},"score":1,"resource":{"primary":{"URL":"https:\/\/oiccpress.com\/pibm\/article\/view\/10466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":219,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["97"],"URL":"https:\/\/doi.org\/10.1007\/s40204-018-0097-y","relation":{},"ISSN":["2194-0509","2194-0517"],"issn-type":[{"value":"2194-0509","type":"print"},{"value":"2194-0517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"1 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standard"}},{"value":"There is no conflict of interest between any of the four authors in this review paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the experiments were performed according to the policies of the Institutional Animal Care and Use Committee at Tehran University of Medical Sciences in accordance with the NIH Guide for the care and use of laboratory animals (NIH publications, 1996).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}